Corneal Infiltrate and Keratitis
I like to keep my notes according to what I will see in clinic
What are the causes of a corneal infiltrate?
AAO PPP
Microbial keratitis
Bacterial, most common includes staphylococcus (typically coagulase negative) and pseudomonas (typically aerginosa)
Fungal
Acathamoebal
Nontuberculous mycobacterium
Non infectious (aka sterile) stromal infiltration (produced by antigens from local or systemic bacterial infection)
Antistaphylococcus associated marginal keratitis
Peripheral ulcerative keratitis secondary to autoimmune disease
What features are characteristic of what differential?
Microbial keratitis in general
AAO PPP
Risk factors of microbial keratitis include:
Recent trauma (e.g. foreign body, corneal laceration, abrasion, surgery etc.)
Existing or recent herpetic (HSV/VZV) disease (e.g. bacterial superimposition)
Contact lens wear (the most common risk factor), particularly with poor hygiene (see “counselling on contact lens hygiene”)
Ocular surface disruptance: dry eye disease (ant/post blepharitis, lagophthalmos, ectropion, punctual ectropion, etc.); RCES, etc.
Features
Corneal infiltrate +/- epitheliai defect
+/- anterior chamber reaction
+/- else
Bacterial keratitis
AAO PPP
Specific risk factors:
Contact lens wear -> ? pseudomonas (check this, this is from memory)
LASIK -> nontuberculous mycobacterium
Trauma -> polymicrobial keratitis (~40% of scrapes may yield two or more organisms)
Features
Infiltrate of the corneal stroma, > 1 mm in size, with white cell infiltration and corneal oedema in the surrounding stroma, hazy margins
+/- epithelial defect +/- antrior chamber reaction
+/- hypopyon
- Hypopyon in bacterial keratitis is typically sterile
Fungal keratitis
AAO PPP
fungal includes yeast and mold
Risk factors
- Plant material (double check)
Features
infiltrate appears dry instead of suppratative
feathered edges
satellite lesions
posterior plaque
A ring lesion is seen in both fungal and acanthamoebal keratitis
A study showed that corneal specialists can visually differentiate between bacterial and fungal keratitis in around 70% of the time (ref below).
Acanthamoebal keratitis
AAO PPP
protozoal parasite
Features:
Inflammation along corneal nerves (called radial keratoneuritis)
Pain out of proportion of findings
A ring lesion is seen in both fungal and acanthamoebal keratitis
Marginal keratitis
What is this, and what is its typical appearance?
Peripheral ulcerative keratitis
What is this, and what is its typical appearance?
When to scrape vs not to scrape?
AAO PPP
here is the checklist:
Hx of ocular surgery involving the cornea
Hx of organic matter (ie gardening etc.)
Presence of >= 1+ cells in the AC
The infiltrate is >/= 2 mm AND within 3 mm of corneal centre
Multiple (2 or more) lesions
Significant stromal involvement or melting
Atypical features (ie suggestive of fungal, amoebic, or mycobacterial)
Poor response to empirical treatment
How to treat?
What drug to prescribe?
Topical antibiotics
Jeremy Williamson
- Topical Cefazolin is for strep cover
AAO PPP - ocular ointments lack solubility, and so are not able to penetrate into the cornea for optimum therapeutic effect. They may be used for adjunctive therapy.
Single drug therapy using fluoroquinolone has been shown to be as effective as combination therapy antibiotics
fortified topicals should be reserved for large infiltrates, visually significant infiltrates, or if hypopyon is present
Single therapy agents include ciprofloxacin 0.3%, ofloxacin 0.3%, and levofloxacin 1.5% in america (FDA)
Consider risk factors for fluoroquinolone resistance (e.g. recent fluoroquinolone use, or realistically, if they use cipro or so long term)
MRSA has high resistance to fluoroquinolones
A cochrane review found no evidence in the rates of corneal perforation between the different antibiotics
you give fortified if sever or unresponsive
pharmacy should prep them
Topical cyloplegia
If there is anterior chamber reaction with bacterial keratitis, cycloplegia may be useful to decrease synechiae formation and decrease pain
PPP
Topical steroids
AAO PPP
a number of studies show there is no difference in clinical outcome with the addition of corticosteroids
there is a theoretical advantage from suppression AC information, which may reduce corneal scarring
There are theoretical risks of recurrence of inection, inhibition of collagen synthesis (predispoing to corneal melt) and increasing IOP
The steroids for corneal ulcer trial foud no benefit of concurrent steroid use with broad spectrum topical antibiotc. But also, this study did not find an increase in the adverse effects in people with bacterial keraetitis (so it sounds here and there).
subgroup analysis revealed a potential benefit in using corticosteroids in two populations:
pseudomonas keratitis
very severe ulcers of bacterial keratitis, ie covering the central 4mm pupil, or VA with CF or worse)
corticosteroids worsened nocardia keratitis
In non-nocardia keratitis, anotehr study foud that addition steroids within 2-3 days of antibiotic therapy (compared to 4 or more days later) resulted in 1 line better.
no clear cut answer
A conservative approach is to avoid prescribing steroids until the organism has been identified, the ED is healing and/or the ulcer is consolidating.
If the ulcer is associated with nocardia or fungus, the outceomes are likely to be poor. There was initial data that showed initial CS use in fungal keratitis had a higher risk for requiring penetrating keratoplasty. Although a more recent trial didn ot find this, still high risk, who knows.
So it seems that:
you must exclude fungal or nordic keratitis before considering steroid therapy
the epithelial defect and the stromal infiltration must both be healing
the benefit of adding corticosteroid is more pronounced when commenced before 4 days, but not at the expense of the above obviously
remember, this is in the presence of AC reaction
if you’re going to start steroid therapy, you shold see them within 2 days of commencing.
make sure to monitor IOP
patients already on corticosteroid for other reasons need to sspend therapy until infection controlled and organism identified.
Frequency and weanne?
For central keratitis (defined earlier as within 3 mm of the centre) or for severe keratitis (defined earlier as > 2 mm with extensive suppuration) a loading dose e.g. every 5 to 15 minutes followed by frequent applications every 1 hour is recommended.
- AAO PPP
Manasi said this is Dr McLintock’s regime q1h for 48h then q1h awake for 5 days Q2h 1 week 6x/d 2 weeks
Prof Jeremy - q1h 48 hours is pretty standard - The rest is guided by clinical response
When to see again?
AAO PPP
severe cases = ie deep stromal involvement, or infiltrates larger than 2mm with extensive suppuration shold be followed daily at least until stable or clinical improvement confirmed
pseudomonas is known to produce increased inflammation int he FIRST 24-48 hours despite appropriate therapy
Here are markers of a positivce response:
decreased pain
decreased discharge
decreased injection
sharper demarcation of the perimetre
decreased densitty of the infiltrate without stromal loss
decreased stromal oedema
decrease in AC cells or hypopyon
ED healing
cessation of corneal thinning if present
you need to taper antibiotics. topical antibiotics cause toxicity
How do you deal with the poor responder? When to re-scrape?
AAO PPP
if there was a negative culture and lack of clinical response, then you can rescrape
do not confuse toxocity of medications or from corticosteroid withdrawal from worsening (this is interesting in people who are already taking steroids before and were susended)
consider discontiuing abx for 12-24 hrs pre reculture,it may increase yoeld
drops containing preservatives (like anaesthetic or cycloplegic agents) shold be avoided
consider other organisms like acanthamoeba, fusariu, atypical mycobacteria
Discharging
When is it safe to discharge?
…
Counselling on good contact lens hygiene
source: bacterial keratitis PPP
Always buy/use official lenses, never online from some dodgy store
Never share lenses with anyone
Do not wear them at night
Do not wear them for longer than the intended lifespan
Never clean them or store them in tape water
Wash your hands before putting them on or off
Make sure their container is clean
Never go swimming, shower with, or even to a hot tub/sauna/spa etc. with them on
old
Good resources, poached from Yanoff’s Ophthalmology
Yanoff Ophthalmology
O’Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol. 1995;113:1257–1265.
Srinivasan M, Mascarenhas J, Rajaraman R, et al. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130:143–150.
Dalmon C, Porco TC, Lietman TM, et al. The clinical differentiation of bacterial and fungal keratitis: A photographic survey. Invest Ophthalmol Vis Sci. 2012;53:1787-1791.
- in this study, 15 corneal specialists were only able to distinguish between bacterial and fungal keratitis in aroud 70% of the time. this shows the importance of getting a scrape. 70% seems pretty good, but not perfect.
Labetoulle M, Frau E, Offret H, et al. Non-preserved 1% lidocaine solution has less antibacterial properties than currently available anaesthetic eye-drops. Curr Eye Res. 2002;25:91-97. - apparently this study showed that topical anaesthetic decreases bacterial yield
cite the AAO PPP for the following table:

extra notes from foreign body keratitis
Always measure the ED and the stromal reaction Always check the fornices well with white light and again with fluorescein Always sweep the fornices Always notify the bosses Always do a posterior segment exam, looking for what??? - penetrating eye injury, but seidel neg, no ac reaction
Always ask if they are contact lens wearer, because that increases the risk of pseudomonas, which ocuflox doesn’t cover (or does it? ocuflox is ofloxacin, which does cover pseudomonas no?)
always document the depth of the infiltrate and the size
References
Bacterial keratitis PPP
See Tolestar and Ario Wilson pogmore article